Shortage reports
Actual shortage:
293 (8%)
Anticipated shortage:
6 (0%)
Avoided shortage:
11 (0%)
Resolved:
3320 (91%)
3630
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
30 (9%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FLUCONAZOLE 150 | 150MG | CAPSULE | Resolved | 2022-02-11 | 2022-04-01 | 154746 |
| HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-03-15 | 2024-04-05 | 222461 |
| HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-02-19 | 2021-04-26 | 134413 |
| HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-01-15 | 2020-03-09 | 103329 |
| IBUPROFEN | 200MG | TABLET | Resolved | 2019-03-13 | 2019-08-28 | 78461 |
| IMIPRAMINE | 50MG | TABLET | Resolved | 2017-03-24 | 2017-03-28 | 4140 |
| IMIPRAMINE | 25MG | TABLET | Resolved | 2021-02-03 | 2021-03-11 | 133186 |
| LORATADINE | 10MG | TABLET | Resolved | 2020-04-13 | 2020-05-19 | 111892 |
| LORATADINE | 10MG | TABLET | Resolved | 2024-06-20 | 2024-07-26 | 231015 |
| MIDODRINE | 5.0MG | TABLET | Resolved | 2017-10-13 | 2018-12-18 | 25869 |
| MIDODRINE | 5.0MG | TABLET | Resolved | 2017-03-28 | 2017-04-14 | 4521 |
| MIDODRINE | 2.5MG | TABLET | Resolved | 2017-10-04 | 2017-10-13 | 24363 |
| MIDODRINE | 2.5MG | TABLET | Resolved | 2017-05-11 | 2017-05-17 | 10043 |
| MIDODRINE | 2.5MG | TABLET | Resolved | 2017-03-21 | 2017-04-14 | 3800 |
| MIRVALA 21 | 0.0300MG 0.1500MG | TABLET | Resolved | 2022-10-21 | 2022-11-07 | 172355 |
| MIRVALA 21 | 0.1500MG 0.0300MG | TABLET | Resolved | 2025-08-07 | 2025-08-15 | 264558 |
| MIRVALA 21 | 0.1500MG 0.0300MG | TABLET | Resolved | 2025-06-05 | 2025-07-12 | 259720 |
| MIRVALA 21 | 0.0300MG 0.1500MG | TABLET | Actual shortage | 2026-02-26 | 2026-02-26 | 279174 |
| MIRVALA 21 | 0.1500MG 0.0300MG | TABLET | Resolved | 2018-07-04 | 2018-07-12 | 54312 |
| MIRVALA 28 | 0.0300MG 0.1500MG | TABLET | Resolved | 2024-08-22 | 2024-10-18 | 235701 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |